Get More From Your Baby’s Cord Blood With ViaCord
ViaCord is revolutionizing cord blood banking by providing families additional health insights by mining the wealth of health information found in your baby’s cord blood. Unlike other cord blood banks, we go beyond reporting standard measurements like collection volume and Total Nucleated Cell count. ViaCord goes beyond the “standard” to provide parents additional insights to help manage the future health of their families at no additional cost. ViaCord is pleased to introduce its Celiac Risk Screen as its first offering in this new and exciting “health insight” segment.
What is Celiac Disease?
Celiac disease is a serious, hereditary autoimmune disease that occurs in genetically predisposed people where the ingestion of gluten leads to damage in the small intestine. When people with celiac disease eat gluten (a protein found in wheat, rye and barley), their body mounts an immune response that attacks the small intestine. These attacks lead to damage on the villi, small finger-like projections that line the small intestine, that promote nutrient absorption. When the villi get damaged, nutrients cannot be absorbed properly into the body. Celiac disease can develop at any age after people start eating foods or medicines that contain gluten. Left untreated, celiac disease can lead to additional serious health problems.
Why Test for Celiac Disease?
Untreated, Celiac Disease can lead to other serious health conditions and autoimmune diseases. Although 97% of those with celiac disease go undiagnosed, earlier diagnosis lowers chance for developing other conditions. Testing for Celiac provides health insights to families and physician on potential for further testing, increased monitoring or intervention.
How is ViaCord’s Celiac Test Run?
As part of ViaCord’s cord blood process, a sample of cord blood is isolated and analyzed utilizing RT PCR (Real-Time Polymerase Chain Reaction) at ViaCord’s CLIA-certified laboratory. The sample used for celiac testing has no impact on the quantity or quality of stem cells processed and stored for your family.
How Will I Receive The Results From ViaCord’s Celiac Risk Screen?
Families will receive the results as part of ViaCord’s standard Cord Blood Results Letter within 6-8 weeks of the cord blood being processed and tested. In addition to the test findings, ViaCord provides those families with a positive finding access to support and resources from Mass General Hospital Center for Celiac Research and Treatment.
What Information Does ViaCord’s Celiac Risk Screen Provide?
Families receive a positive (+) or negative (-) for the presence of HLA (Human Leukocyte Antigens) gene alleles DQ2 and DQ8. A positive finding doesn’t mean your child will develop celiac disease, but your doctor may determine the need for additional monitoring or testing. However, a negative finding means your child cannot develop celiac disease or pass it on to their children. Learn more about the genetics associated with Celiac Disease.
Who is Eligible for ViaCord’s Celiac Risk Screen?
Currently, the Celiac Risk Screen is available to all families collecting cord blood excluding collections taking place in the State of New York.
Disclaimer: PerkinElmer does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.